Different Types of Belly Fat and What They Mean

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

Belly fat is not one thing — visceral fat wraps around organs and drives metabolic disease, while subcutaneous fat sits under the skin and is metabolically safer. Visceral fat suppresses adiponectin and contributes to insulin resistance; waist above 40 inches in men or 35 in women signals elevated risk. Where fat is stored matters more than total body weight.

Read more →

Understand what your hormones belly fat results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

You've been eating well, moving consistently, and the scale is finally budging. But your midsection looks exactly the same. Or maybe you've noticed fat accumulating in a pattern you've never seen before, concentrated in your lower abdomen or wrapping around your waist like a spare tire. The frustration isn't just aesthetic. Where your body stores fat, and what type of fat it's storing, tells a story about what's happening inside your metabolism, your hormones, and your stress response.

What's actually happening when fat accumulates in your belly

Belly fat isn't one thing. It's two distinct types of tissue with completely different metabolic behaviors. Subcutaneous fat is the soft, pinchable layer that sits directly under your skin. Visceral fat, by contrast, lies deep in your abdominal cavity, packed between and around your liver, intestines, and other organs. You can't see it or feel it from the outside, but it's metabolically active in ways that subcutaneous fat is not.

Visceral fat behaves like an endocrine organ. It secretes inflammatory cytokines, releases free fatty acids directly into your portal circulation, and interferes with insulin signaling. This is why two people with the same waist circumference can have vastly different metabolic health. One might carry mostly subcutaneous fat. The other might be storing visceral fat around their organs, driving insulin resistance, elevated triglycerides, and systemic inflammation.

When your body decides where to store incoming calories as fat, it's responding to hormonal signals. Insulin directs fat into cells. Cortisol shifts storage toward the abdomen. Estrogen, when present in sufficient amounts, tends to favor the hips and thighs. Testosterone influences upper body fat. The pattern you see in the mirror reflects the hormonal environment inside your body over weeks and months.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

How belly fat affects metabolism, hormones, and inflammation

Visceral fat doesn't just sit there. It releases adipokines, signaling molecules that communicate with the rest of your body. Some of these molecules, like adiponectin, improve insulin sensitivity when levels are high. But visceral fat suppresses adiponectin production while pumping out pro-inflammatory cytokines like interleukin-6 and tumor necrosis factor-alpha, which interfere with insulin receptor function and promote systemic inflammation.

Because visceral fat drains directly into the portal vein, the free fatty acids it releases flood your liver first. This overwhelms the liver's capacity to process fat, leading to hepatic insulin resistance and elevated triglyceride production. Your liver starts packaging excess fat into VLDL particles, raising your triglycerides and lowering your HDL cholesterol. This lipid pattern, combined with insulin resistance, is the hallmark of metabolic syndrome.

Subcutaneous fat, especially in the hips and thighs, behaves differently. It stores energy without the same inflammatory cascade. In fact, gluteofemoral fat produces more adiponectin and less inflammatory signaling. This is why pear-shaped individuals tend to have better metabolic health even at higher body weights.

The adrenal body type and stress-driven fat storage

The term adrenal body type describes a pattern of fat accumulation driven by prolonged cortisol elevation. When you're under chronic stress, whether from work, sleep deprivation, or emotional strain, your adrenal glands release cortisol continuously. Over time, this leads to a characteristic fat distribution: a rounded midsection, often with a lower belly bulge, while the arms and legs remain relatively lean.

Cortisol doesn't just promote fat storage. It also breaks down muscle tissue to provide amino acids for gluconeogenesis, the process your liver uses to make glucose when blood sugar drops. This means chronic stress can simultaneously increase abdominal fat and decrease muscle mass, worsening your body composition and slowing your metabolic rate.

Apple-shaped fat and insulin resistance

An apple-shaped body, where fat accumulates around the waist and upper abdomen, is strongly associated with insulin resistance. This pattern reflects a metabolic state where your cells no longer respond efficiently to insulin's signal to take up glucose. In response, your pancreas secretes more insulin to compensate. High insulin levels, in turn, promote fat storage, particularly in the abdomen, creating a vicious cycle.

Visceral fat itself worsens insulin resistance by releasing free fatty acids and inflammatory molecules that block insulin signaling in muscle and liver tissue. This is why waist circumference is a better predictor of metabolic disease than BMI. A waist measurement above 40 inches in men or 35 inches in women signals elevated visceral fat and increased risk for type 2 diabetes, cardiovascular disease, and fatty liver.

Menopause and the shift to abdominal fat

During menopause, estrogen levels decline sharply. Estrogen influences where your body stores fat by regulating the activity of lipoprotein lipase, an enzyme that controls fat deposition. When estrogen is present, fat tends to accumulate in the hips and thighs. When estrogen drops, fat shifts to the abdomen. This explains why many women notice a change in body shape during perimenopause and menopause, even if their weight stays stable.

This shift isn't just cosmetic. The transition from subcutaneous to visceral fat increases metabolic risk. Postmenopausal women experience higher rates of insulin resistance, dyslipidemia, and cardiovascular disease, partly because of this redistribution of fat. Hormone replacement therapy, when appropriate, can partially improve this pattern by restoring estrogen's protective effect on fat distribution.

What drives different types of belly fat

Stress and sleep deprivation

Chronic stress elevates cortisol, which promotes visceral fat storage and increases appetite for calorie-dense foods. Poor sleep amplifies this effect. Sleep deprivation raises cortisol and ghrelin, your hunger hormone, while suppressing leptin, which signals satiety. The result is increased calorie intake and preferential storage of those calories as abdominal fat.

Insulin resistance and dietary patterns

Insulin resistance, often driven by a diet high in refined carbohydrates and low in fiber, creates a state where your body overproduces insulin. High insulin levels block fat oxidation and promote fat storage, particularly in the abdomen. Diets high in added sugars and trans fats promote visceral fat accumulation, while diets rich in protein, fiber, and healthy fats improve satiety, stabilize blood sugar, and reduce the hormonal signals that drive abdominal fat storage. Alcohol, particularly in excess, is metabolized in the liver and promotes both hepatic fat accumulation and visceral fat deposition.

Physical activity and muscle mass

Sedentary behavior reduces insulin sensitivity and allows visceral fat to accumulate unchecked. Resistance training builds muscle mass, which improves insulin sensitivity and shifts your body toward fat oxidation rather than fat storage. Moderate aerobic exercise reduces cortisol over time and directly targets visceral fat.

Why the same diet produces different fat patterns in different people

Genetic predisposition

Genetics play a significant role in determining where your body stores fat. Some individuals are genetically predisposed to store fat in their hips and thighs, a pattern associated with better metabolic health. Others are predisposed to central fat storage, which carries higher risk. These patterns are influenced by variations in genes that regulate fat cell development, hormone receptor sensitivity, and inflammatory responses.

Sex hormones and hormonal conditions

Men, with higher testosterone and lower estrogen, tend to store fat in the abdomen. Women, with higher estrogen, tend to store fat in the hips and thighs until menopause, when the pattern shifts. Individuals with polycystic ovary syndrome, a condition characterized by elevated androgens, often develop an apple-shaped fat distribution similar to men.

Repeated cycles of weight loss and regain can increase the proportion of visceral fat relative to subcutaneous fat. This happens because visceral fat is more metabolically active and refills more quickly after weight loss. Muscle mass, which is often lost during calorie restriction, doesn't return as easily, leaving you with a higher body fat percentage and a greater proportion of that fat stored viscerally.

As you age, muscle mass declines and fat mass increases, even if your weight stays the same. This shift in body composition, called sarcopenic obesity, is associated with increased visceral fat and worsening metabolic health. Hormonal changes, particularly the decline in growth hormone and sex hormones, accelerate this process.

Individual stress response

Stress resilience varies widely. Some individuals have a more reactive hypothalamic-pituitary-adrenal axis, meaning their cortisol response to stress is exaggerated. These individuals are more likely to develop stress-driven abdominal fat. Others have a blunted cortisol response, which can also be problematic, leading to fatigue and difficulty mobilizing fat for energy.

Test 150+ biomarkers

Two blood draws. A full picture of your health, explained in plain language.

Book your test

Turning fat distribution into actionable metabolic insight

Understanding your fat distribution helps you identify which metabolic pathways need attention. If you're carrying excess visceral fat, the priority is improving insulin sensitivity and reducing systemic inflammation. This means focusing on blood sugar control, measuring fasting insulin and hemoglobin A1c, and tracking inflammatory markers like high-sensitivity C-reactive protein.

If your fat distribution suggests cortisol dysregulation, the focus shifts to stress management, sleep quality, and adrenal support. Measuring morning cortisol or a four-point cortisol curve can reveal whether your stress response is chronically elevated or blunted. Tracking sleep duration and quality, along with subjective stress levels, provides context for interpreting these results.

For women experiencing a shift in fat distribution during perimenopause or menopause, measuring estradiol, follicle-stimulating hormone, and luteinizing hormone can clarify whether hormonal changes are driving the pattern. Tracking body composition over time, rather than just weight, reveals whether you're losing muscle or gaining visceral fat, even if the scale stays stable.

Waist circumference is a simple, powerful tool. Measure at the level of your navel, without pulling the tape tight. A measurement above 40 inches in men or 35 inches in women signals elevated visceral fat and increased metabolic risk. Tracking this measurement over time, alongside biomarkers like fasting insulin, triglycerides, and HDL cholesterol, gives you a clearer picture of whether your interventions are working.

Body composition testing, whether through DEXA scan, bioelectrical impedance, or skinfold measurements, distinguishes between fat mass and lean mass. This matters because weight loss without muscle preservation worsens metabolic health. The goal isn't just to lose weight. It's to lose fat, particularly visceral fat, while maintaining or building muscle.

How Superpower helps you track the metabolic drivers behind belly fat

If you're trying to understand why your body stores fat where it does, Superpower's 150+ biomarker panel gives you the data you need. Fasting insulin, hemoglobin A1c, and the triglyceride-to-HDL ratio reveal insulin resistance. High-sensitivity C-reactive protein and other inflammatory markers show whether visceral fat is driving systemic inflammation. Cortisol, along with thyroid hormones and sex hormones, clarifies whether hormonal imbalances are shifting your fat distribution. Tracking these markers over time, rather than relying on a single snapshot, shows you whether your interventions are moving the needle.

Frequently Asked Questions

References

  1. Cartier A, Lemieux I, Alméras N, Tremblay A, Bergeron J, Després JP (2008). Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men. *The Journal of clinical endocrinology and metabolism*, *93*(5), 1931-8. https://doi.org/10.1210/jc.2007-2191
  2. Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, Cuevas A, Hu FB, Griffin BA, Zambon A, Barter P, Fruchart JC, Eckel RH, Matsuzawa Y, Després JP (2020). Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. *Nature reviews. Endocrinology*, *16*(3), 177-189. https://doi.org/10.1038/s41574-019-0310-7
  3. Manolopoulos KN, Karpe F, Frayn KN (2010). Gluteofemoral body fat as a determinant of metabolic health. *International Journal of Obesity*, *34*(6), 949-959. https://doi.org/10.1038/ijo.2009.286
  4. Alser M, Naja K, Elrayess MA (2024). Mechanisms of body fat distribution and gluteal-femoral fat protection against metabolic disorders. *Frontiers in Nutrition*, *11*, 1368966. https://doi.org/10.3389/fnut.2024.1368966
  5. Escobar-Morreale HF, San Millán JL (2007). Abdominal adiposity and the polycystic ovary syndrome. *Trends in Endocrinology and Metabolism*, *18*(7), 266-272. https://doi.org/10.1016/j.tem.2007.07.003

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Biological age 32 — a Superpower member portraitA health system built around you — test, understand, optimize150+ biomarkers across 2 blood drawsWhat to expect with Superpower — week 1 to month 3Trusted by 64,000+ customers — member reviewsBetter than the status quo — Superpower vs the old way60% of members found something a doctor missed — member survey
Daniel OSuperpower memberDavid LSuperpower memberRachel DSuperpower memberCamelia VSuperpower member

4.6 · 64,000+ members

Superpower health membership

Find early signs of 1,000+ conditions - then act, retest, and see what changed.

$349

/year*

150+ biomarkers annually across baseline + retest

Personalized plan that turns results into action

Superpower AI and on-demand care team

Results in 10 days or less

At-home or 2,000+ labs nationwide**

Yearly membership$0.96 / dayHSA/FSA eligible

*Pricing may vary for members in New York and New Jersey

**At-home labs for an additional cost

What we test

TestosteroneFree T4Vitamin DApoBHbA1cThyroid (TSH)hs-CRPFerritinCortisolFasting insulin

60%

found something a doctor missed

93%

rated it more useful than their checkup

77%

found something new in their results

Superpower member survey, 90 days post action plan (n=143).

How does the Superpower membership work?

We test 150+ biomarkers annually across two blood draws. Your baseline test paints a comprehensive picture of your health, and your dashboard shows what’s working, what needs attention, and what to do next. Superpower AI and your care team help you take action across lifestyle, supplements, and treatments. Then we retest to track your progress and continue refining your plan.

Can I cancel anytime?

Yes. You can cancel anytime, no fees. Your membership stays active through the end of your paid year.

How often should I test?

Your membership includes two blood tests per year: one to establish your baseline, and one to see whether your plan improved biomarkers that were out of range or not yet optimized. You can add other diagnostics anytime through the app or with help from your care team.

When will I get my results?

Book your draw at any of 2,000+ partner labs or at-home. Results are typically ready in about a week and land in the Superpower app.

What the 100+ panel measures

All 101 markers in your annual baseline draw, organized by system. Nothing here is an upsell.

Heart & Vascular Health

26

  • Apolipoprotein B
  • Atherogenic Coefficient
  • Atherogenic Index of Plasma
  • Castelli Risk Index I
  • Castelli Risk Index II
  • HDL Cholesterol
  • LDL Cholesterol
  • LDL/HDL Ratio
  • Cholesterol, Total
  • Non-HDL Cholesterol
  • Cholesterol/HDL Ratio
  • Carbon Dioxide, Total
  • High-sensitivity CRP
  • hsCRP-to-Albumin Ratio (CAR)
  • GGT-to-HDL Cholesterol Ratio
  • LDL-C to Apolipoprotein B Ratio (LDL-C/ApoB)
  • LDL Cholesterol / Total Cholesterol (Mass Ratio)
  • Monocyte-to-HDL Ratio (MHR)
  • Neutrophil-to-HDL Cholesterol Ratio (NHR)
  • Non-HDL Cholesterol-to-Apolipoprotein B Ratio (Non-HDL-C/ApoB)
  • NON-HDL Total Cholesterol Ratio
  • Triglyceride HDL Molar Ratio
  • Triglycerides
  • Triglyceride-to-Apolipoprotein B Ratio (TG/ApoB)
  • TyG Index
  • Uric Acid

Metabolic Health

4

  • Estim. Avg Glu (eAG)
  • Eag (mmol/l)
  • Glucose
  • Hemoglobin A1c

Energy

1

  • Cortisol

Liver Health

15

  • Albumin/Globulin Ratio
  • Albumin
  • Alkaline Phosphatase (ALP)
  • Alanine Aminotransferase (ALT)
  • Aspartate Aminotransferase (AST)
  • Bilirubin Direct
  • Bilirubin Indirect
  • Bilirubin, Total
  • Bilirubin-to-Albumin Ratio
  • Ferritin
  • Ferritin-to-Albumin Ratio
  • y-Glutamyl Transferase (GGT)
  • Globulin, Total
  • Indirect-to-Direct Bilirubin Ratio
  • Protein, Total

Kidney

11

  • Calcium
  • Chloride
  • Corrected Calcium (Albumin-adjusted)
  • Creatinine
  • Estimated Glomerular Filtration Rate (eGFR)
  • Potassium
  • Sodium
  • BUN/Creatinine Ratio
  • Blood Urea Nitrogen (BUN)
  • Urea-to-Creatinine Ratio
  • Uric Acid-to-HDL Cholesterol Ratio (UHR)

Sex Hormones

7

  • DHEA-Sulfate (DHEA-S)
  • Free Androgen Index
  • Sex Hormone Binding Globulin (SHBG)
  • Free Testosterone
  • Testosterone, Bioavailable
  • Testosterone, Total
  • Testosterone-to-Estradiol Ratio (T/E₂)

Thyroid Health

4

  • Free Thyroxine Index
  • T3 Uptake
  • T4 (thyroxine) Total
  • Thyroid-Stimulating Hormone (TSH)

Nutrients

13

  • Vitamin D
  • Red Cell Dist Width (RDW)
  • Hematocrit
  • Hemoglobin
  • Total Iron Binding Capacity (TIBC)
  • Iron
  • Iron Saturation
  • Mean Cell Hemoglobin (MCH)
  • Mean Corpuscular Hemoglobin Concentration (MCHC)
  • Mean Cell Volume (MCV)
  • Platelet-to-WBC Ratio (PWR)
  • Red Blood Cells
  • RDW MCV Ratio

Immune System

12

  • Basophils
  • Baso (Absolute)
  • Eosinophils
  • Eos (Absolute)
  • Lymphocytes
  • Lymphs (Absolute)
  • Monocytes
  • Monocytes (Absolute)
  • Neutrophils
  • Neutrophils (Absolute)
  • Mean Platelet Volume
  • Platelet Count

Inflammation

8

  • Lymphocyte-to-Monocyte Ratio (LMR)
  • Monocyte-to-Lymphocyte Ratio (MLR)
  • Neutrophil-to-Lymphocyte-Platelet Ratio (NLPR)
  • Neutrophil-to-Lymphocyte Ratio (NLR)
  • Platelet-to-Lymphocyte Ratio (PLR)
  • Systemic Immune-Inflammation Index
  • Systemic Inflammation Response Index (SIRI)
  • White Blood Cells
Get my health baseline

The full list of 100+ markers and 8 specialty add-ons available at superpower.com/what-we-test.